Inolimomab |
B-B10; BT-563; MAb-BT-563 |
Phase 3 Clinical |
Eusa Pharma, Jazz Pharmaceuticals Plc |
Graft vs Host Disease |
Details
|
Nemvaleukin alfa |
RDB-1419; RDB-1450; ALKS-4230 |
Phase 3 Clinical |
Alkermes Plc |
Ovarian Neoplasms; Solid tumours; Skin Melanoma; Squamous Cell Carcinoma of Head and Neck; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Melanoma |
Details
|
Basiliximab biobetter (Mabtech/Sorrento) |
STI-003 |
Phase 3 Clinical |
Taizhou Maibo Taike Biotechnology Co Ltd |
Autoimmune Diseases |
Details
|
PT-101 |
PT-101; MK-6194; PT101 |
Phase 2 Clinical |
Pandion Therapeutics |
Lupus Erythematosus, Systemic; Colitis, Ulcerative; Dermatitis, Atopic; Vitiligo |
Details
|
LMB-2 |
LMB-2; LMB-2a |
Phase 2 Clinical |
National Cancer Institute |
Leukemia; Leukemia, Hairy Cell; Myeloproliferative Disorders; Myelodysplastic Syndromes; Skin Neoplasms; Leukemia-Lymphoma, Adult T-Cell; Lymphoma; Myelodysplastic-Myeloproliferative Diseases; Melanoma |
Details
|
Camidanlumab tesirine |
ADCT-301 |
Phase 2 Clinical |
Adc Therapeutics Sa, Genmab A/S |
Myeloproliferative Disorders; Melanoma; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Colorectal Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Urinary Bladder Neoplasms; Myelodysplastic Syndromes; Ovarian Neoplasms; Pancreatic Neoplasms; Triple Negative Breast Neoplasms; Hodgkin Disease; Carcinoma, Renal Cell; Stomach Neoplasms; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Solid tumours |
Details
|
90Y Basiliximab |
|
Phase 2 Clinical |
City Of Hope National Medical Center |
Lymphoma, T-Cell, Peripheral; Hodgkin Disease; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute; Lymphoma, T-Cell, Cutaneous; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell |
Details
|
MDNA-11 |
MDNA-11; MDNA11 |
Phase 2 Clinical |
Medicenna Therapeutics Corp |
Triple Negative Breast Neoplasms; Melanoma; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms; Endometrial Neoplasms; Carcinoma, Squamous Cell; Peritoneal Neoplasms; Mesothelioma; Urinary Bladder Neoplasms; Skin Neoplasms; Solid tumours; Carcinoma, Ovarian Epithelial; Stomach Neoplasms; Carcinoma, Merkel Cell; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Esophageal Neoplasms; Gastrointestinal Diseases; Carcinoma, Basal Cell; Ovarian Neoplasms; Skin Melanoma |
Details
|
Anti-interleukin-2 receptor monoclonal antibody Mikbeta1 |
HuMikβ1-1 |
Phase 1 Clinical |
F. Hoffmann-La Roche Ltd, National Institutes Of Health |
Leukemia; Leukemia, Lymphoid; Celiac Disease; Paraparesis, Tropical Spastic; Leukemia, Large Granular Lymphocytic |
Details
|
Vopikitug |
RO-7296682; RG-6292 |
Phase 1 Clinical |
F. Hoffmann-La Roche Ltd |
Solid tumours; Neoplasms |
Details
|
BA-1106 |
TS-1904; BA-1106; RR-102 |
Phase 1 Clinical |
|
Solid tumours; Neoplasms |
Details
|
XmAb-564 |
XmAb-564; XmAb-27564 |
Phase 1 Clinical |
Xencor Inc |
Autoimmune Diseases; Psoriasis; Dermatitis, Atopic |
Details
|
IL2 CD25 fusion protein (Bristol-Myers Squibb) |
|
Phase 1 Clinical |
University Of Miami |
Autoimmune Diseases |
Details
|
9MW-3911 |
9MW3911; 9MW-3911 |
Phase 1 Clinical |
Nanjing Nuo Aixin Biotechnology Co Ltd |
Neoplasms |
Details
|
In 111-DOTA-Basiliximab |
|
Phase 1 Clinical |
City Of Hope National Medical Center |
Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute |
Details
|
BMS-986326 |
BMS-986326 |
Phase 1 Clinical |
Bristol-Myers Squibb Company |
Lupus Vulgaris; Dermatitis, Atopic |
Details
|
Humanized Anti-CD25 Antibody(Institute of Hematology & Blood Diseases Hospital) |
|
|
Institute Of Hematology & Blood Diseases Hospital |
|
Details
|
Inolimomab |
B-B10; BT-563; MAb-BT-563 |
Phase 3 Clinical |
Eusa Pharma, Jazz Pharmaceuticals Plc |
Graft vs Host Disease |
Details
|
Nemvaleukin alfa |
RDB-1419; RDB-1450; ALKS-4230 |
Phase 3 Clinical |
Alkermes Plc |
Ovarian Neoplasms; Solid tumours; Skin Melanoma; Squamous Cell Carcinoma of Head and Neck; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Melanoma |
Details
|
Basiliximab biobetter (Mabtech/Sorrento) |
STI-003 |
Phase 3 Clinical |
Taizhou Maibo Taike Biotechnology Co Ltd |
Autoimmune Diseases |
Details
|
PT-101 |
PT-101; MK-6194; PT101 |
Phase 2 Clinical |
Pandion Therapeutics |
Lupus Erythematosus, Systemic; Colitis, Ulcerative; Dermatitis, Atopic; Vitiligo |
Details
|
LMB-2 |
LMB-2; LMB-2a |
Phase 2 Clinical |
National Cancer Institute |
Leukemia; Leukemia, Hairy Cell; Myeloproliferative Disorders; Myelodysplastic Syndromes; Skin Neoplasms; Leukemia-Lymphoma, Adult T-Cell; Lymphoma; Myelodysplastic-Myeloproliferative Diseases; Melanoma |
Details
|
Camidanlumab tesirine |
ADCT-301 |
Phase 2 Clinical |
Adc Therapeutics Sa, Genmab A/S |
Myeloproliferative Disorders; Melanoma; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Colorectal Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Urinary Bladder Neoplasms; Myelodysplastic Syndromes; Ovarian Neoplasms; Pancreatic Neoplasms; Triple Negative Breast Neoplasms; Hodgkin Disease; Carcinoma, Renal Cell; Stomach Neoplasms; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Solid tumours |
Details
|
90Y Basiliximab |
|
Phase 2 Clinical |
City Of Hope National Medical Center |
Lymphoma, T-Cell, Peripheral; Hodgkin Disease; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute; Lymphoma, T-Cell, Cutaneous; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell |
Details
|
MDNA-11 |
MDNA-11; MDNA11 |
Phase 2 Clinical |
Medicenna Therapeutics Corp |
Triple Negative Breast Neoplasms; Melanoma; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms; Endometrial Neoplasms; Carcinoma, Squamous Cell; Peritoneal Neoplasms; Mesothelioma; Urinary Bladder Neoplasms; Skin Neoplasms; Solid tumours; Carcinoma, Ovarian Epithelial; Stomach Neoplasms; Carcinoma, Merkel Cell; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Esophageal Neoplasms; Gastrointestinal Diseases; Carcinoma, Basal Cell; Ovarian Neoplasms; Skin Melanoma |
Details
|
Anti-interleukin-2 receptor monoclonal antibody Mikbeta1 |
HuMikβ1-1 |
Phase 1 Clinical |
F. Hoffmann-La Roche Ltd, National Institutes Of Health |
Leukemia; Leukemia, Lymphoid; Celiac Disease; Paraparesis, Tropical Spastic; Leukemia, Large Granular Lymphocytic |
Details
|
Vopikitug |
RO-7296682; RG-6292 |
Phase 1 Clinical |
F. Hoffmann-La Roche Ltd |
Solid tumours; Neoplasms |
Details
|
BA-1106 |
TS-1904; BA-1106; RR-102 |
Phase 1 Clinical |
|
Solid tumours; Neoplasms |
Details
|
XmAb-564 |
XmAb-564; XmAb-27564 |
Phase 1 Clinical |
Xencor Inc |
Autoimmune Diseases; Psoriasis; Dermatitis, Atopic |
Details
|
IL2 CD25 fusion protein (Bristol-Myers Squibb) |
|
Phase 1 Clinical |
University Of Miami |
Autoimmune Diseases |
Details
|
9MW-3911 |
9MW3911; 9MW-3911 |
Phase 1 Clinical |
Nanjing Nuo Aixin Biotechnology Co Ltd |
Neoplasms |
Details
|
In 111-DOTA-Basiliximab |
|
Phase 1 Clinical |
City Of Hope National Medical Center |
Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute |
Details
|
BMS-986326 |
BMS-986326 |
Phase 1 Clinical |
Bristol-Myers Squibb Company |
Lupus Vulgaris; Dermatitis, Atopic |
Details
|
Humanized Anti-CD25 Antibody(Institute of Hematology & Blood Diseases Hospital) |
|
|
Institute Of Hematology & Blood Diseases Hospital |
|
Details
|